4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-001601
Chief Operating Officer gave up 10,553 shares (to pay taxes)
- Chief Operating Officer acquired 18,850 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BILINSKY IGOR Chief Operating Officer | 2023-01-03 | Option exercise | +18,850 | 28,354 | D: show line 1 in the form | ||
| BILINSKY IGOR Chief Operating Officer | 2023-01-03 | Shares withheld for taxes | −10,553 | $6.11 | $64,479 | 17,801 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BILINSKY IGOR Chief Operating Officer | 2023-01-03 | Option exercise · Restricted Stock Units | −18,850 | 0 | D: show line 3 in the form |
Loading xslF345X03/tm232380d2_4seq1.xml…